Investors following Cathie Wood’s ARK ETFs closely watched as the funds executed a series of trades on Tuesday, January 21, 2025, with significant transactions in both buying and selling across various sectors.
Topping the list, ARK sold a substantial stake in Accolade Inc (NASDAQ:) through its ARKG ETF, offloading 466,337 shares for a total value of approximately $3.2 million. This move continued a selling trend for Accolade, as ARK had previously reduced its position in the company on the prior Friday.
In contrast, ARK showed confidence in Deere & Co (NYSE:) by acquiring a total of 3,474 shares split between its ARKQ and ARKX (NYSE:) ETFs, amounting to a significant investment of over $1.5 million. This purchase suggests a bullish stance on the industrial sector and Deere’s growth prospects.
Another notable buy was in Cameco Corp (NYSE:), a uranium producer, with ARKQ ETF purchasing 17,504 shares valued at roughly $903,731. This investment aligns with ARK’s focus on innovative and forward-thinking companies.
ARK also continued to increase its holdings in Intellia Therapeutics Inc (NASDAQ:), a leader in gene editing technology, by adding 91,889 shares across ARKK and ARKG ETFs, with a total value nearing $873,000. This follows ARK’s strategy of investing in disruptive innovation in the healthcare sector.
Additional trades included a sale of 2,701 shares of Elbit Systems Ltd (NASDAQ:) for about $804,411, and a sale of 50,333 shares of Oklo Inc (NASDAQ:OKLO) totaling around $1.3 million. ARK also reduced its position in UiPath Inc (NYSE:) by selling 21,879 shares, valued at approximately $284,864.
Investors also noted ARK’s purchase of 15,876 shares of Illumina Inc (NASDAQ:), although the dollar value was not disclosed. Illumina has been a recurring name in ARK’s trades, indicating a steady interest in the genomics company.
The daily trade report reflects ARK’s dynamic investment strategy, as Cathie Wood’s funds adapt to market movements and continue to seek out companies poised for disruptive growth. Investors will be watching closely to see how these trades play out in the context of ARK’s broader portfolio strategy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
